Trial intelligence / Profile preview

Short-term effects of low-concentration atropine eye drops and myopic retinal defocus on choroidal thickness and choroidal blood flow

jRCT1031240082Recruiting

Start
May 2024
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of atropine in myopia, sponsored by none. Primary endpoints: choroidal blood flow and choroidal thickness. Started May 2024; status: recruiting.

02

Drugs

atropine
03

Conditions

myopia

Beyond the preview

Go deeper on jRCT1031240082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031240082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call